Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Liver Diseases

  Free Subscription


1 AJR Am J Roentgenol
2 Am J Pathol
1 BMC Cancer
1 Br J Surg
2 Dig Dis Sci
2 Eur Radiol
6 Hepatology
3 Int J Cancer
4 J Gastroenterol Hepatol
3 J Hepatol
1 Oncogene
2 Radiology
2 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    AJR Am J Roentgenol

  1. TIPIRNENI-SAJJA A, Krafft AJ, McCarville MB, Loeffler RB, et al
    Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2* MRI.
    AJR Am J Roentgenol. 2017 May 15:1-8. doi: 10.2214/AJR.16.17183.
    PubMed     Text format     Abstract available

    Am J Pathol

  2. HOLZER K, Drucker E, Roessler S, Dauch D, et al
    Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer.
    Am J Pathol. 2017;187:228-235.
    PubMed     Text format     Abstract available

  3. KYRITSI K, Meng F, Zhou T, Wu N, et al
    Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.
    Am J Pathol. 2017 May 11. pii: S0002-9440(17)30044.
    PubMed     Text format     Abstract available

    BMC Cancer

  4. YANG S, Wang XQ
    XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
    BMC Cancer. 2017;17:344.
    PubMed     Text format     Abstract available

    Br J Surg

  5. VAN ROSMALEN BV, Coelen RJS, Bieze M, van Delden OM, et al
    Systematic review of transarterial embolization for hepatocellular adenomas.
    Br J Surg. 2017;104:823-835.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  6. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    PubMed     Text format     Abstract available

  7. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available

    Eur Radiol

  8. HWANG J, Kim YK, Min JH, Choi SY, et al
    Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
    Eur Radiol. 2017 May 12. doi: 10.1007/s00330-017-4846.
    PubMed     Text format     Abstract available

  9. ZHENG G, Lu H, Yu W, Luo S, et al
    Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4809.
    PubMed     Text format     Abstract available


  10. POSSO-OSORIO I, Mendez-Rayo T, Andres Jimenez C, Escobar D, et al
    Hepatic infiltration by silicone in a patient with asia syndrome.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29274.
    PubMed     Text format    

  11. CHO CS, Lombard DB, Lee JH
    SIRT3 as a Regulator of Hepatic Autophagy.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29271.
    PubMed     Text format    

  12. HAN D, Li J, Wang H, Su X, et al
    Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29270.
    PubMed     Text format     Abstract available

  13. BUENDIA MA, Armengol C, Cairo S
    Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29262.
    PubMed     Text format    

  14. SAFIRI S, Ayubi E
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis: Methodological issues.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29261.
    PubMed     Text format    

  15. ZHANG QY, Zhao LP, Tian XX, Yan CH, et al
    The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29257.
    PubMed     Text format     Abstract available

    Int J Cancer

  16. LEE TY, Wu JC, Yu SH, Lin JT, et al
    The occurrence of hepatocellular carcinoma in different risk stratifications of clinically non-cirrhotic non-alcoholic fatty liver disease.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30784.
    PubMed     Text format     Abstract available

  17. CHU YJ, Yang HI, Wu HC, Liu J, et al
    Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30782.
    PubMed     Text format     Abstract available

  18. MA X, Yang Y, Li HL, Zheng W, et al
    Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China.
    Int J Cancer. 2017;140:1050-1059.
    PubMed     Text format     Abstract available

    J Gastroenterol Hepatol

  19. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
    Performance of magnetic resonance elastography in primary sclerosing cholangitis.
    J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
    PubMed     Text format     Abstract available

  20. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
    The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
    J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
    PubMed     Text format     Abstract available

  21. KIM Y, Lee EJ, Jang HK, Kim CH, et al
    Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
    PubMed     Text format     Abstract available

  22. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    PubMed     Text format     Abstract available

    J Hepatol

  23. SHIN WJ, Hwang GS
    Reply to: "Pressure volume curves in cirrhosis: more than meets the eye".
    J Hepatol. 2017 May 9. pii: S0168-8278(17)32010.
    PubMed     Text format    

  24. ASHHAB AA, Rodin H, Powell J, Debes JD, et al
    Hepatocellular carcinoma diagnosis and surveillance: Socioeconomic factors don't seem to matter, unless you are an immigrant.
    J Hepatol. 2017 May 10. pii: S0168-8278(17)32012.
    PubMed     Text format    

  25. WANG Q, Lv Y, Bai M, Wang Z, et al
    Eight millimeter covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    J Hepatol. 2017 May 12. pii: S0168-8278(17)32015.
    PubMed     Text format     Abstract available


  26. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  27. GOSHIMA S, Bae KT
    Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.
    Radiology. 2017;283:921-922.
    PubMed     Text format    

  28. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Radiology. 2017;283:923.
    PubMed     Text format    


  29. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available

  30. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.